Diloxanide furoate

Diloxanide
Systematic (IUPAC) name
4-[(dichloroacetyl)(methyl)amino]phenyl furan-2-carboxylate
Clinical data
Trade names Furamide
AHFS/Drugs.com Micromedex Detailed Consumer Information
Pregnancy
category
  • No available data
Legal status
  • Not approved (US, CA)
Routes of
administration
Oral
Pharmacokinetic data
Bioavailability 90% (diloxanide)
Metabolism Hydrolyzed to furoic acid and diloxanide, which undergoes extensive glucuronidation
Biological half-life 3 hours
Excretion Renal (90%), fecal (10%)
Identifiers
CAS Number 3736-81-0 N
ATC code P01AC01
PubChem CID 19529
DrugBank DB08792 YesY
ChemSpider 18400 YesY
KEGG D02480 YesY
ChEMBL CHEMBL1334860 N
Chemical data
Formula C14H11Cl2NO4
Molar mass 328.147 g/mol
 NYesY (what is this?)  (verify)

Diloxanide furoate is a luminal amebicide used in the treatment of Amebiasis.[1] It is considered the luminal agent of choice for mild intestinal amebiasis or asymptomatic cyst carriers. It can also be added to metronidazole (active drug in luminal and extraintestinal amebiasis) in acute amebic dysentery as well as hepatic abscess(In hepatic abscess it is for the control of cysts in the lumen which may cause relapse). The drug was discovered by The Boots Company Plc in 1956 and introduced as Furamide. The Furamide brand is now owned by Abbott Laboratories. It is not available in the US. In India it is available as Amicline by Franco-Indian.

It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.[2]

Safety and effectiveness

A 13-year study conducted by the United States Center for Disease Control between 1977 and 1990 found that this drug had a low incidence of side effects and was successful in treatment of 86% of asymptomatic carriers of Entamoeba histolytica.[3]

References

  1. Fernandes H, D'Souza CR, Swethadri GK, Naik CN (2009). "Ameboma of the colon with amebic liver abscess mimicking metastatic colon cancer". Indian J Pathol Microbiol 52 (2): 228–30. doi:10.4103/0377-4929.48927. PMID 19332922.
  2. "WHO Model List of Essential Medicines" (PDF). World Health Organization. October 2013. Retrieved 22 April 2014.
  3. McAuley JB, Herwaldt BL, Stokes SL; et al. (1992). "Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States". Clin. Infect. Dis. 15 (3): 464–8. doi:10.1093/clind/15.3.464. PMID 1520794.


This article is issued from Wikipedia - version of the Sunday, January 17, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.